EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Clinical importance of laboratory biomarkers in liver fibrosis

Goda Aleknavičiūtė-Valienė, Valdas Banys

Biochemia medica · 15.10.2022 · 32 (3) · 346-356

DOI: 10.11613/bm.2022.030501 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemia medica, online erschienen am 29.09.2022. Verfasst von Goda Aleknavičiūtė-Valienė und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center of Laboratory Medicine,Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania. Hauptthemen laut MEDLINE: Collagen Type IV, Laminin. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic cirrhosis is a major health problem across the world, causing high morbidity and mortality. This disease has many etiologies, yet the result of chronic hepatic injury is hepatic fibrosis causing cirrhosis and hepatocellular carcinoma, as the liver’s architecture is progressively destroyed. While liver biopsy is currently the gold standard for fibrosis staging, it has significant disadvantages, leading to a growing interest in non-invasive markers. Direct biomarkers – hyaluronic acid, laminin, collagen type III N-peptide, type IV collagen and cholylglycine – are new and rarely applied in routine clinical practice. This is the case primarily because there is no general consensus regarding the clinical application and effectiveness of the individual biomarkers. The usage of these markers in routine clinical practice could be advantageous for patients with liver fibrosis, requiring a simple blood test instead of a biopsy. The former option would be especially attractive for patients who are contraindicated for the latter. This review summarizes recent findings on direct biomarkers of liver fibrosis and highlights their possible applications and potential benefit for liver fibrosis diagnostics and/or staging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type IVLamininHumansCollagen Type IIIHyaluronic AcidLiver CirrhosisBiomarkersGlycocholic Acid

Stichwörter der Autor:innen

biomarkerscholylglycinecollagenhepatic fibrosishyaluronic acidlaminin

Substanzen

Collagen Type IVLamininCollagen Type IIIHyaluronic AcidBiomarkersGlycocholic Acid

Autor:innen und Institutionen

  • Center of Laboratory Medicine,Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Zitieren

APA

Aleknavičiūtė-Valienė, G., & Banys, V. (2022). Clinical importance of laboratory biomarkers in liver fibrosis. Biochemia medica, 32(3), 346-356. https://doi.org/10.11613/bm.2022.030501

Vancouver

Aleknavičiūtė-Valienė G, Banys V. Clinical importance of laboratory biomarkers in liver fibrosis. Biochemia medica. 2022;32(3):346-356. doi:10.11613/bm.2022.030501

BibTeX
@article{AleknaviitValien2022,
  author = {Aleknavičiūtė-Valienė, Goda and Banys, Valdas},
  title = {Clinical importance of laboratory biomarkers in liver fibrosis},
  journal = {Biochemia medica},
  year = {2022},
  volume = {32},
  number = {3},
  pages = {346--356},
  doi = {10.11613/bm.2022.030501}
}
Kostenlos starten →